USD459798S1 - Pill tablet - Google Patents

Pill tablet Download PDF

Info

Publication number
USD459798S1
USD459798S1 US29/148,657 US14865701F USD459798S US D459798 S1 USD459798 S1 US D459798S1 US 14865701 F US14865701 F US 14865701F US D459798 S USD459798 S US D459798S
Authority
US
United States
Prior art keywords
pill tablet
view
pill
tablet
opposite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/148,657
Inventor
Christian Desesquelle
Philippe Becourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BECOURT, PHILIPPE, DESESQUELLE, CHRISTIAN
Application granted granted Critical
Publication of USD459798S1 publication Critical patent/USD459798S1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a top view of our pill tablet design;
FIG. 2 is a bottom view thereof;
FIG. 3 is a long side view thereof;
FIG. 4 is an opposite long side view thereof;
FIG. 5 is a short side view thereof;
FIG. 6 is an opposite short side view;
FIG. 7 is a top view showing an embodiment of our pill tablet design;
FIG. 8 is a bottom view thereof;
FIG. 9 is a long side view thereof;
FIG. 10 is an opposite long side view thereof;
FIG. 11 is a short side view thereof;
FIG. 12 is an opposite short side view;
FIG. 13 is a top view showing another embodiment of our pill tablet design;
FIG. 14 is a long side view thereof;
FIG. 15 is an opposite long side view thereof;
FIG. 16 is a short side view thereof;
FIG. 17 is an opposite short side view;
FIG. 18 is a top view showing another embodiment of our pill tablet design;
FIG. 19 is a long side view thereof;
FIG. 20 is an opposite long side view thereof;
FIG. 21 is a short side view thereof; and,
FIG. 22 is an opposite short side view.

Claims (1)

  1. The ornamental design for pill tablet, substantially as shown and described.
US29/148,657 2001-03-26 2001-09-24 Pill tablet Expired - Lifetime USD459798S1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR011861 2001-03-26
FR0101861 2001-03-26

Publications (1)

Publication Number Publication Date
USD459798S1 true USD459798S1 (en) 2002-07-02

Family

ID=8859888

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/148,657 Expired - Lifetime USD459798S1 (en) 2001-03-26 2001-09-24 Pill tablet

Country Status (1)

Country Link
US (1) USD459798S1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD666377S1 (en) * 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD666376S1 (en) * 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) * 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) * 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD795525S1 (en) * 2016-03-16 2017-08-29 Intercontinental Great Brands Llc Confection
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine
US11466278B2 (en) 2016-11-01 2022-10-11 Novo Nordisk A/S Temperature based plasmid regulation system

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD666377S1 (en) * 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD666376S1 (en) * 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) * 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD787043S1 (en) * 2015-06-23 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD795525S1 (en) * 2016-03-16 2017-08-29 Intercontinental Great Brands Llc Confection
USD821682S1 (en) 2016-03-16 2018-07-03 Intercontinental Great Brands Llc Confection
US11466278B2 (en) 2016-11-01 2022-10-11 Novo Nordisk A/S Temperature based plasmid regulation system
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835258S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD858741S1 (en) * 2017-02-22 2019-09-03 Celgene Corporation Pharmaceutical tablet
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD1039677S1 (en) * 2019-03-19 2024-08-20 Novo Nordisk A/S Pill
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine

Similar Documents

Publication Publication Date Title
USD482284S1 (en) Frusto-conical container
USD475929S1 (en) Bottle
USD459798S1 (en) Pill tablet
USD469693S1 (en) Lid
USD485354S1 (en) Tampon
USD454497S1 (en) Bottle
USD459233S1 (en) Ring shaped bottle
USD456257S1 (en) Cap
USD452436S1 (en) Bottle
USD447427S1 (en) Watch
USD433148S (en) Pill crusher
USD466810S1 (en) Liner
USD477866S1 (en) Round tablet
USD484062S1 (en) Watch
USD435228S (en) Nail ring
USD476567S1 (en) Lid
USD501400S1 (en) Bottle
USD472114S1 (en) Turbotune drumkey
USD474419S1 (en) Diamond
USD474700S1 (en) Watch
USD467773S1 (en) Spice mill
USD463851S1 (en) Stopper
USD430662S (en) Vitamin tablet
USD429329S (en) Vitamin tablet
USD472008S1 (en) Chandelier